Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JBT Marel's Current Accrued Expense for the quarter that ended in Jun. 2026 was kr19,300 Mil.
JBT Marel's quarterly Current Accrued Expense
declined
from Dec. 2025 (kr20,874 Mil) to Mar. 2026 (kr18,931 Mil) but then
increased
from Mar. 2026 (kr18,931 Mil) to Jun. 2026 (kr19,300 Mil).
JBT Marel's annual Current Accrued Expense
declined
from Dec. 2023 (kr7,339 Mil) to Dec. 2024 (kr6,798 Mil) but then
increased
from Dec. 2024 (kr6,798 Mil) to Dec. 2025 (kr20,874 Mil).
The historical data trend for JBT Marel's Current Accrued Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.
What does a Current Accrued Expense of kr19,300 Mil mean?
JBT Marel (OISE:JBTM) has a Current Accrued Expense of kr19,300 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on JBT Marel and its competitors.
Is JBT Marel's Current Accrued Expense too high?
JBT Marel's current Current Accrued Expense is kr19,300 Mil. Overall, JBT Marel has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JBT Marel's Current Accrued Expense compare to NPO and GTES?
JBT Marel's Current Accrued Expense of kr19,300 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for an Industrial Products company?
A good Current Accrued Expense depends on the Industrial Products industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on JBT Marel and its competitors. JBT Marel's current Current Accrued Expense is kr19,300 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JBT Marel stock overvalued right now?
Based on GuruFocus' analysis, JBT Marel (OISE:JBTM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr18,474.53, compared to a current price of kr14,300.00 — trading 22.6% below its estimated fair value. The current Current Accrued Expense is kr19,300 Mil. JBT Marel's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For JBT Marel (OISE:JBTM), the current Current Accrued Expense is kr19,300 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JBT Marel (OISE:JBTM) Overvalued in 2026?
Based on GuruFocus' analysis, JBT Marel stock appears to be undervalued.
The current stock price of kr14,300.00 is trading 22.6% below its estimated GF Value™ of kr18,474.53.
GuruFocus considers JBT Marel to be Modestly Undervalued.
Key valuation signals for OISE:JBTM:
Current Accrued Expense: kr19,300 Mil
GF Value™: kr18,474.53 vs. price of kr14,300.00 (22.6% below fair value)
No single metric tells the full story. See the OISE:JBTM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JBT Marel Corp operates through two reportable segments: Protein Solutions and Prepared Food and Beverage Solutions. The Protein Solutions segment includes businesses that provide solutions for the initial stage processing and harvesting of animal proteins, mainly focusing on poultry, pork, fish, and beef. The Prepared Food and Beverage Solutions segment includes businesses that offer solutions predominantly for downstream value-added preparation, preservation, and packaging of foods and beverages into ready-to-eat or drink products. This segment will also include capabilities for pet food, dairy, bakery, pharmaceutical, nutraceutical, and warehouse automation end markets. The majority of its revenue is generated from the Prepared Food and Beverage Solutions segment.
74GF Score
Get the complete analysis for OISE:JBTM
Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OISE:JBTM has been successfully added to your 
